Skip to content
Bored Studies
RecruitingPhase 1/Phase 2

Opt-IVF for Personalized Medicine for Normal Responders

Urmila DIwekar · NCT07856082

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 20–50 · Women only
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 1, Phase 2
Target enrollment
100
US sites recruiting
1
Study start
October 15, 2026
Record last updated
October 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

Being studied: Opt-IVF; control

Conditions: Ivf

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Normal Responders

Exclusion Criteria

  • PCOS and Poor Responders

Recruiting US locations

  • ABC IVF

    West Palm Beach, FL 33407

    Site contact: Dr. Paul Magarelli, M.D., Ph.D. · 630-886-3047 · paul@americanbabyco.com

Study contacts (from the official record)

  • Urmila Diwekar, Ph.D. · 6308863047 · urmila@opt-ivf.com
  • Sanjay Joag, M.D., Ph.D. · 6305014451 · sanjay@opt-iVF.com
All women’s health studies in Florida →
Opt-IVF for Personalized Medicine for Normal Responders (NCT07856082) | Bored Studies